Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study
Endoscopy International Open · 06.11.2026 · 14 (CP)
DOI: 10.1055/a-2992-1623 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Endoscopy International Open, online erschienen am 06.11.2026. Verfasst von David Andreas Roser und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of GastroenterologyUniversity Hospital AugsburgAugsburgBavariaGermany. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Augsburg University.
Abstract (Originalsprache)
In Western countries without screening programs, Helicobacter pylori infection, gastric atrophy, and intestinal metaplasia must be detected opportunistically during endoscopy, yet real-world data on how reliably this occurs are scarce. We determined their histologic prevalence among biopsied diagnostic gastroscopies and how completely they are recorded in routine endoscopy reports. Retrospective single-center cross-sectional study of all diagnostic gastroscopies with gastric biopsies at a tertiary university hospital (2016–2025). Documentation of each lesion was compared with institutional histopathology reports. As only biopsied examinations were eligible, concordance measures reporting completeness. Prevalence was analyzed at patient level (n = 9,852) and concordance at examination level (n = 11,381). H. pylori infection or any gastric precancerous condition was present in 31.4% of patients (H. pylori 11.5%, atrophy 6.6%, intestinal metaplasia 21.5%). A corresponding finding was recorded in the endoscopy report in 9.6% (95% CI 8.0–11.4) of H. pylori-positive, 9.2% (8.1–10.3) of metaplasia-positive and 49.4% (45.8–52.9) of atrophy-positive examinations. Counting rapid urease tests, which indicate H. pylori testing but not written mucosal suspicion, increased documentation to 46.0%. Results were similar with antrum-and-corpus sampling (90.7%; ≤0.7 percentage points). The publication of MAPS-II or newer endoscopy generations did not increase documentation substantially. H. pylori infection and gastric precancerous conditions affected nearly one-third of biopsied patients, yet most histologically confirmed findings were not explicitly documented at endoscopy. Closing this documentation gap should be a priority for integrating gastric cancer risk assessment into routine endoscopic reporting.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of GastroenterologyUniversity Hospital AugsburgAugsburgBavariaGermany.
- Medical FacultyUniversity Hospital AugsburgAugsburgBavariaGermany.
- Institute of Digital MedicineUniversity Hospital AugsburgAugsburgBavariaGermany.
- Institute of EpidemiologyUniversity Hospital AugsburgAugsburgBavariaGermany.
ORCID-Profile: David Andreas Roser, Andreas Probst, Christoph Römmele
Förderung
- Augsburg University
Zitieren
APA
Roser, D. A., Ganthaler, H., Probst, A., Ignatenko, Y., Freuer, D., Messmann, H., & Römmele, C. (2026). Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study. Endoscopy International Open, 14(CP). https://doi.org/10.1055/a-2992-1623
Vancouver
Roser DA, Ganthaler H, Probst A, Ignatenko Y, Freuer D, Messmann H, et al. Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study. Endoscopy International Open. 2026;14(CP). doi:10.1055/a-2992-1623
BibTeX
@article{Roser2026,
author = {Roser, David Andreas and Ganthaler, Hanna and Probst, Andreas and Ignatenko, Yevgeniia and Freuer, Dennis and Messmann, Helmut and Römmele, Christoph},
title = {Prevalence and Endoscopic Documentation of Helicobacter pylori and Gastric Precancerous Conditions in Routine Gastroscopy with Biopsies: A Cross-Sectional Study},
journal = {Endoscopy International Open},
year = {2026},
volume = {14},
number = {CP},
doi = {10.1055/a-2992-1623}
}
EUVIMED